Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)
Clinical trial NCT00790894 · TERMINATED
Trial details
- NCT number
- NCT00790894
- Sponsor
- Hellenic Cooperative Oncology Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2011-04-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.